Skip to Content
Morningstar

Elevance Health Inc ELV

Morningstar Rating
Unlock
Stock XNYS Rating as of
$539.68 +5.95 (1.11%)
View Full Chart
As of Delayed Price Post-Trading: $538.50 −1.00
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Elevance Earnings: Mix Shift Boosts Bottom Line and 2024 Outlook Slightly

Julie Utterback

Narrow-moat Elevance delivered slightly higher first-quarter results than expected and mildly increased its 2024 guidance, despite continued medical membership losses from Medicaid eligibility redeterminations. Our near- and long-term forecasts have not changed materially, and we do not anticipate changing our $520 fair value estimate. Recent trades appear close to fair value.

Read Full Report

Price vs Fair Value

View History
ELV is trading within a range we consider fairly valued.
Price
$532.22
Fair Value
$595.00
Uncertainty
Medium
1-Star Price
$459.00
5-Star Price
$863.00
Economic Moat
Glbzlv
Capital Allocation
Nggyjdvhr

Bulls Say, Bears Say

Bulls

Elevance continues to use its scale-related advantages for the benefit of clients, and we remain intrigued by its ongoing efforts to align incentives with caregivers, including the deployment of high performance provider networks.

Bears

The insurance and PBM industries will likely remain targets of regulators aiming to reduce the healthcare cost burden on society, which is its key ESG risk, in our opinion.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELV is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$533.73
Day Range
$534.96–542.07
52-Week Range
$412.00–542.07
Bid/Ask
$515.00 / $599.98
Market Cap
$125.43 Bil
Volume/Avg
1.1 Mil / 978,338

Key Statistics

Price/Earnings (Normalized)
15.50
Price/Sales
0.73
Dividend Yield (Trailing)
1.14%
Dividend Yield (Forward)
1.22%
Total Yield
3.25%

Company Profile

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Sector
Healthcare
Industry
Healthcare Plans
Stock Style Box
Large Value
Total Number of Employees
—
Website
https://www.elevancehealth.com

Competitors

Valuation

View More
Metric
ELV
HUM
CI
Price/Earnings (Normalized)
 15.5013.2514.05
Price/Book Value
 3.042.362.23
Price/Sales
 0.730.360.54
Price/Cash Flow
 13.7111.3412.58
Price/Earnings
ELV
HUM
CI

Financial Strength

Metric
ELV
HUM
CI
Quick Ratio
 ———
Current Ratio
 ———
Interest Coverage
 8.497.864.81
Quick Ratio
No chart available

Profitability

Metric
ELV
HUM
CI
Return on Assets (Normalized)
 7.36%5.46%5.00%
Return on Equity (Normalized)
 20.87%17.15%16.44%
Return on Invested Capital (Normalized)
 13.85%11.21%10.56%
Return on Assets
ELV
HUM
CI
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Healthcare Plans Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
UNH
UnitedHealth Group IncYyjmzgwjklWgbrh$448.4 Bil
CI
The Cigna GroupDmxxrxckLbkpjqq$100.0 Bil
CVS
CVS Health CorpWjzngfzhMqjcwnd$85.4 Bil
CNC
Centene CorpDvrnhmytHrbyd$40.8 Bil
HUM
Humana IncKwnxdhsLsbxp$38.1 Bil
MOH
Molina Healthcare Inc—Wbsfvt$21.2 Bil
OSCR
Oscar Health Inc Class A—Trds$4.0 Bil
ALHC
Alignment Healthcare Inc—Vlfk$978.9 Mil
CLOV
Clover Health Investments Corp Ordinary Shares - Class A—Vky$321.9 Mil

Sponsor Center